Gemcitabine Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for solution for injection/infusion
Available Strengths: 200 mg, 1000 mg, 1500 mg
Reference Brands: Gemzar® (US & EU)
Category:
Oncology Cancer Care
Gemcitabine is an FDA- and EMA-approved oncology drug used to treat various cancers, including lung, pancreatic, and breast cancer. Available in 200 mg, 1 g, and 1.5 g vials for IV infusion, it is widely supplied across the US and EU pharmaceutical B2B markets. Reliable sourcing and quality assurance make it a key chemotherapy product for hospitals and clinics.
Gemcitabine is available in Lyophilized powder for solution for injection/infusion
and strengths such as 200 mg, 1000 mg, 1500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gemcitabine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gemcitabine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gemcitabine is a widely used oncology chemotherapy drug available in both the US and EU pharmaceutical B2B markets. Offered in 200 mg, 1 g, and 1.5 g vials, Gemcitabine comes as a lyophilized powder for intravenous infusion. Trusted by hospitals and oncology centers, it is essential for treating cancers such as pancreatic, lung, bladder, and breast cancer. Approved by the FDA and EMA, Gemcitabine is available through certified pharmaceutical wholesalers and B2B distributors across Europe and the United States. Buyers seeking reliable Gemcitabine suppliers can access competitive pricing, consistent quality, and regulatory-compliant sourcing for hospital and clinical use.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing